Satraplatin
- Generic Name
- Satraplatin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C10H22Cl2N2O4Pt
- CAS Number
- 129580-63-8
- Unique Ingredient Identifier
- 8D7B37T28G
- Background
Satraplatin is a platinum compound that is currently under investigation as one treatment of patients with advanced prostate cancer who have failed previous chemotherapy. As an investigation drug, it has not yet received U.S. Food and Drug Administration (FDA) approval and is not available in retail pharmacies.
- Indication
Investigated for use/treatment in lung cancer, prostate cancer, and solid tumors.
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath